Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF assays for direct detection of mycobacterium tuberculosis complex and resistance markers in respiratory and extrapulmonary specimens

Journal of Clinical Microbiology

Volumn 54, Issue 12, 2016, Pages 3022-3027

  Hofmann Thiel, Sabine ^a,b   Molodtsov, Nikolay ^b   Antonenka, Uladzimir ^b   Hoffmann, Harald ^a,b  

^a SYNLAB ACADEMY   (Germany)

^b ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FLUOROTYPE MTB; GENETIC MARKER; GENOTYPE MTBDRPLUS; GERMANY; HUMAN; INHA GENE; INTERMETHOD COMPARISON; KATG GENE; LIMIT OF DETECTION; MICROSCOPY; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; MYCOBACTERIUM XENOPEI; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REAL TIME MTB ASSAY; RPOB GENE; SENSITIVITY AND SPECIFICITY; SMEAR MICROSCOPY; ATYPICAL MYCOBACTERIUM; DRUG EFFECTS; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANCE; PROCEDURES; TUBERCULOSIS, PULMONARY;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 84997784963     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01144-16     Document Type: Article

References (26)

1. World Health Organization. 2015. Global tuberculosis report 2015. World Health Organization, Geneva, Switzerland. 2. Sharma SK, Kohli M, Yadav RN, Chaubey J, Bhasin D, Sreenivas V, Sharma R, Singh BK. 2015. Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PLoS One 10:e0141011. http: //dx.doi.org/10.1371/journal.pone.0141011.
2. Park KS, Kim JY, Lee JW, Hwang YY, Jeon K, Koh WJ, Ki CS, Lee NY. 2013. Comparison of the Xpert MTB/RIF and Cobas TaqMan MTB assays for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 51:3225-3227. http://dx.doi.org/10.1128/JCM.01335-13.
3. Tortoli E, Urbano P, Marcelli F, Simonetti TM, Cirillo DM. 2012. Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples? J Clin Microbiol 50:2810- 2813. http://dx.doi.org/10.1128/JCM.01412-12.
4. Jonsson B, Lonnermark E, Ridell M. 2015. Evaluation of the Cobas TaqMan MTB test for detection of Mycobacterium tuberculosis complex. Infect Dis (Lond) 47:231-236. http://dx.doi.org/10.3109/00365548.2014 .987162.
5. Hofmann-Thiel S, Hoffmann H. 2014. Evaluation of FluoroType MTB for detection of Mycobacterium tuberculosis complexDNAin clinical specimens from a low-incidence country. BMC Infect Dis 14:59. http://dx.doi .org/10.1186/1471-2334-14-59.
6. Lim J, Kim J, Kim JW, Ihm C, Sohn YH, Cho HJ, Koo SH. 2014. Multicenter evaluation of Seegene Anyplex TB PCR for the detection of Mycobacterium tuberculosis in respiratory specimens. J Microbiol Biotechnol 24:1004-1007. http://dx.doi.org/10.4014/jmb.1403.03071.
7. Casali N, Nikolayevskyy V, Balabanova Y, Harris SR, Ignatyeva O, Kontsevaya I, Corander J, Bryant J, Parkhill J, Nejentsev S, Horstmann RD, Brown T, Drobniewski F. 2014. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 46:279- 286. http://dx.doi.org/10.1038/ng.2878.
8. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 377:1495-1505. http://dx.doi .org/10.1016/S0140-6736(11)60438-8.
9. Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC. 2016. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J 48:516-525. http://dx.doi.org/10.1183/13993003.00543-2016.
10. Mirzayev F, Gemert Wv, Gilpin C, Weyer K. 2014. Xpert MTB/RIF implementation manual. Technical and operational "how-to": Practical considerations. World Health Organization, Geneva, Switzerland.
11. Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP. 2012. Global isoniazid resistance patterns in rifampin-resistant and rifampinsusceptible tuberculosis. Int J Tuberc Lung Dis 16:203-205. http://dx.doi .org/10.5588/ijtld.11.0445.
12. Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J. 2012. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. Int J Tuberc Lung Dis 16:812-816.
13. Barnard M, Gey van Pittius NC, van Helden PD, Bosman M, Coetzee G, Warren RM. 2012. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol 50:3712-3716. http://dx.doi.org/10.1128 /JCM.01958-12.
14. Sali M, De Maio F, Caccuri F, Campilongo F, Sanguinetti M, Fiorentini S, Delogu G, Giagulli C. 2016. Multicenter evaluation of Anyplex plus MTB/NTM MDR-TB assay for rapid detection of Mycobacterium tuberculosis complex and multidrug-resistant isolates in pulmonary and extrapulmonary specimens. J Clin Microbiol 54:59-63. http://dx.doi.org/10.1128 /JCM.01904-15.
15. Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S. 2012. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One 7:e36966. http://dx.doi .org/10.1371/journal.pone.0036966.
16. Tang N, Frank A, Pahalawatta V, Lampinen J, Coblenz-Korte A, Dunn C, Li C, Cloherty G, Abravaya K, Leckie G. 2015. Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimens. Tuberculosis (Edinb) 95: 613-619. http://dx.doi.org/10.1016/j.tube.2015.05.010.
17. Kent PT, Kubica GP. 1985. Public health microbiology: A guide for the level III laboratory. Centers for Disease Control, Atlanta, GA.
18. Rieder HL, Van Deun A, Kam KM, Kim SJ, Chonde TM, Trébucq A, Urbanczik R. 2007. Priorities for tuberculosis bacteriology services in low-income countries, 2nd ed. International Union against Tuberculosis and Lung Diseases, Paris, France.
19. Bai Y, Wang Y, Shao C, Hao Y, Jin Y. 2016. GenoType MTBDRplus assay for rapid detection of multidrug resistance in Mycobacterium tuberculosis: A meta-analysis. PLoS One 11:e0150321. http://dx.doi.org/10 .1371/journal.pone.0150321.
20. Schnippel K, Rosen S, Shearer K, Martinson N, Long L, Sanne I, Variava E. 2013. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health 18:109-116. http://dx .doi.org/10.1111/tmi.12018.
21. Unitaid. 2015. Tuberculosis diagnostics technology and market landscape, 4th ed. World Health Organization, Geneva, Switzerland.
22. Chen JH, She KK, Kwong TC, Wong OY, Siu GK, Leung CC, Chang KC, Tam CM, Ho PL, Cheng VC, Yuen KY, Yam WC. 2015. Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens. Eur J Clin Microbiol Infect Dis 34:1827-1832. http://dx.doi.org/10.1007 /s10096-015-2419-5.
23. Vinuesa V, Navarro D, Poujois S, Zaragoza S, Borras R. 2016. Performance characteristics of the new Abbott Real Time MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens. Diagn Microbiol Infect Dis 84:212-214. http://dx.doi.org/10.1016 /j.diagmicrobio.2015.11.001.
24. Wang SF, Ou XC, Li Q, Zheng HW, Wang YF, Zhao YL. 2016. The Abbott RealTimeMTBassay and the Cepheid GeneXpert assay show comparable performance for the detection of Mycobacterium tuberculosis in sputum specimens. Int J Infect Dis 45:78-80. http://dx.doi.org/10.1016/j .ijid.2016.02.024.
25. Sharma K, Appannanavar SB, Modi M, Singh M, Sharma A, Varma S. 2015. Role of multiplex polymerase chain reaction using IS6110 and protein b for the diagnosis of extra-pulmonary tuberculosis: North India. Indian J Pathol Microbiol 58:27-30. http://dx.doi.org/10.4103/0377-4929 .151164.
26. Huyen MN, Tiemersma EW, Kremer K, de Haas P, Lan NT, Buu TN, Sola C, Cobelens FG, van Soolingen D. 2013. Characterisation of Mycobacterium tuberculosis isolates lacking IS6110 in Viet Nam. Int J Tuberc Lung Dis 17:1479-1485. http://dx.doi.org/10.5588/ijtld.13.0149.